Clinical use of antiviral drugs Flashcards

1
Q

What are the difficulties in developing a safe anti-viral?

A
  • Viruses use cellular receptors to get inside cells
  • Genetic integration - no way to reverse it
  • Latency is common - then no real target while dormant
  • High mutation rate
  • Must replicate inside cells and take over host’s biochemistry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do we use antivirals?

A
  • treatment of acute infection
  • Post-exposure prophylaxis and preventing infection
  • Post-exposure prophylaxis and allowing infection
  • Pre-exposure prophylaxis
  • Prophylaxis for reactivated infection (e.g. in transplant after immunosuppression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What drugs can we use for herpes?

A
  • Aciclovir/valaciclovir (IV/oral/topical) - HSV and VSV
  • Gangciclovir/ valgangciclovir (IV/oral) - CMV
  • Foscarnet (IV/topical)
  • Cidofovir (IV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the mechanism of action of aciclovir?

A
  • Aciclovir is very closely related to guanosine
  • Our body take ACV into the cell, then gets phosphorylated by a HSV derived thymidine kinase
  • Our own TK can then phosphorylate it twice
  • When guanosine is being incorporated into the growing DNA, ACV takes its place, inhibitng the DNA synthesis
  • This means that the virus cannot replicate and so dies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is aciclovir used for?

A
•	Herpes simplex
–	Treatment of encephalitis
–	Treatment of genital infection
–	suppressive therapy for recurrent genital herpes
•	Varicella zoster virus
–	Treatment of chickenpox
–	Treatment of shingles
–	Prophylaxis of chickenpox
•	CMV
–	Prophylaxis only
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is ganciclovir used for?

A

• CMV
• Goes into latent phase and can come back
– Treatment of reactivated infection in organ transplant recipients
– Treatment of congenital infection in newborn
– Prophylaxis in organ transplant recipients (if donor had latent CMV)
• Mismatch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the difference between valaciclovir/ valaganciclovir and their normal versions?

A
  • By adding valine ester on it, it is more bioavailable

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can Herpes viruses become resistant to antivirals?

A
  • Two main mechanisms = thymidine kinase mutants and DNA polymerase mutants
  • If occurs in TK, drugs not needing phosphorylation are still effective (foscarnet and cidofovir)
  • If occurs in DNA polymerase, all drugs are rendered less effective
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What drugs can we use for influenza?

A
  • Amantidine - inhibits virus uncoating by blocking the influenza encoded M2 protein when inside cells, and assembly of HA (now rarely used)
  • Zanamivir and Oseltamivir - inhibits release from infected cells via inhibition of NA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How effective are NA inhibitors?

A
  • Marginal overall benefit
  • Treatment needs to be commenced early
  • Very useful in post-exposure prophylaxis or in the flu season
  • Resistance is rare, but more likely in immunocompromised patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does resitance to antivirals occur in influenza?

A
  • Resistance sometimes only requires a single amino acid change - seen recently with swine flu (H1N1) and Tamiflu (oseltamivir)
  • Point mutation (H275Y; tyrosine replacing histidine)
  • Seen in immunocompromised patients; shed virus for weeks/months
  • Likely to be selected for among quasispcies on Rx
  • Transmissible and virulent
  • Remains sensitive to zanamivir; probably because of low levels of exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do we treat HepB?

A
  • For a long time we used IFN to treat pts with chronic infections, however can have some bad side effects
  • Specific anti-virals - Lamivudine, tenofovir, entecavir, adefovir
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do we treat HepC?

A
  • HCV is curable in some
  • Response influenced by viral genotype and host genotype
  • Treat with pegylated IFN and ribavirin
  • However starting to produce specific antivirals and IFN-free treatments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does the HIV virus infect us?

A
  • gp120 binds to the CD4 receptor and CCR5 co-receptor, followed by penetration and uncoating
  • The RNA is then reverse transcribed into a DNA provirus, which is integrated into the cell genome
  • Makes mRNA for new proteins and genomic RNA to produce new strains
  • Followed by synthesis and maturation of virus progeny
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are anti-retrovirals?

A

The drugs do not kill or cure the virus. However, when taken in combination they can prevent the growth of the virus. When the virus is slowed down, so is HIV disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give 6 examples of anti-retrovirals

A
  • nucleoside reverse transcriptase inhibitors (NRTIs)
  • nucleotide reverse transcriptase inhibitors (NtRTIs)
  • Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
  • Protease inhibitors (PIs)
  • CCR5 inhibitors - inhibit the virus getting in in the first place
  • Integrase inhibitors
17
Q

What is the basis of HIV therapy?

A
  • Complicated
  • Combination approach - reduces risk of drug resistance
  • Multiple viral enzyme targets (reverse transcriptase, protease, integrase, viral receptor binding proteins)
  • Adherence to treatment is essential
18
Q

Give 3 viral infections that are still not treatable

A
  • Rabies
  • Dengue
  • Common cold